October 2010
Price: £150 PLUS VAT
Format: DOWNLOADABLE PDF
This timely seminar examined the future role and scope of NICE (National Institute for Health and Clinical Excellence) which has emerged as a focus for health policy in the new Parliament.
It took into account recent developments in the Government's White Paper 'Equity and excellence: Liberating the NHS' which calls for a radical shake-up of health services and commissioning, including an advanced role for NICE in commissioning as well as the signaled intention to 'reform NICE and move to a system of value-based pricing, so that all patients can access the drugs and treatments their doctors think they need'.
The seminar included keynote presentations from NICE and the ABPI, sessions focused on challenges and opportunities for the UK's pharmaceutical industry; balancing clinical need and cost effectiveness including discussion around the Cancer Drugs Fund; and perspectives on patient outcomes, tackling inequalities in the commissioning of medicine and delivering patient choice.
